enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. PSA prepayment model - Wikipedia

   en.wikipedia.org/wiki/PSA_prepayment_model

   Variations of the model are expressed in percent, e.g., "150% PSA" means a monthly increase of 0.3% in the annualized prepayment rate, until the peak of 9% is reached after 30 months. The months thereafter have a constant annualized prepayment rate of 9%. 1667% PSA is roughly equivalent to 100% prepayment rate in month 30 or later.

3. Candel Therapeutics Stock Surges Over 100% - Here's Why - AOL

   www.aol.com/candel-therapeutics-stock-surges...

   A significant increase in the proportion of patients achieving a prostate-specific antigen (PSA) nadir (<0.2 ng/ml) was observed in the treatment arm compared to the placebo control arm (67.1% vs ...

4. Prostate-specific antigen - Wikipedia

   en.wikipedia.org/wiki/Prostate-specific_antigen

   Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.

5. Progression-free survival - Wikipedia

   en.wikipedia.org/wiki/Progression-free_survival

   Progression may also be due to the appearance of a new lesion or to unequivocal progression in other lesions, such as an increase in size or the lesions spreading to nearby tissues. Progression-free survival is commonly used as an alternative to overall survival (OS). In some cancers, PFS and OS are strictly related, but in others they are not.

6. Biochemical recurrence - Wikipedia

   en.wikipedia.org/wiki/Biochemical_recurrence

   Biochemical recurrence is a rise in the blood level of prostate-specific antigen (PSA) in prostate cancer patients after treatment with surgery or radiation. Biochemical recurrence may occur in patients who do not have symptoms. It may mean that the cancer has come back. Also called PSA failure and biochemical relapse. [1]

7. Benign prostatic hyperplasia - Wikipedia

   en.wikipedia.org/wiki/Benign_prostatic_hyperplasia

   The prevalence of clinically diagnosed BPH peaks at 24% in men aged 75–79 years. [3] Based on autopsy studies, half of males aged 50 and over are affected, and this figure climbs to 80% after the age of 80. [3] Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate ...